Our proprietary technologies are purpose-built to overcome the most complex formulation and drug delivery challenges across topical, transdermal, mucosal, ophthalmic, and respiratory applications. From automated high-throughput testing systems like MedFlux-HT® for skin permeation studies to specialized models like ChubTur® for hard tissue and nail penetration, our technologies drive faster, more predictive development. These exclusive platforms not only accelerate product timelines but also generate robust, regulatory-ready data that improves confidence in formulation performance and clinical success. MedPharm’s proprietary solutions offer clients a distinct scientific and competitive advantage, helping them navigate regulatory hurdles and deliver best-in-class therapies to market.
MedSpray® is a patented formulation technology developed by MedPharm, referred to as a “patch-in-a-can.” It is designed for various applications by leaving a thin film on the skin or other tissue surfaces
Unique design features along with automated collection provide significant reduction in variation associated with sampling and fluidics compared to manually operated VDC systems.
MedFlux-HT® is an automated system of 32 flow-through diffusion cells for measuring the in vitro permeation and penetration of drugs into and through human skin (IVPT) . It can also be set up with other tissues determined by the medicine’s target site (e.g. mucosal, buccal, etc).
EyeVPT is a proprietary device that mimics the tear and clearance mechanism across regrown cornea.
Proprietary system that keeps skin alive for more than 30 days for topical and systemic treatment assessment.
MedCast revolutionizes nasal drug delivery research with advanced anatomical modeling. It goes beyond serving as a physical replica of the nasal cavity by providing actionable insights into formulation behavior, deposition patterns, and functional performance across diverse patient demographics and delivery objectives.